Integrity Alliance LLC. Purchases 10,583 Shares of UnitedHealth Group Incorporated $UNH

Key Points

• Integrity Alliance LLC significantly increased its stake in UnitedHealth Group by 376.4% in the first quarter, owning 13,395 shares valued at approximately $7 million after acquiring an additional 10,583 shares.
• UnitedHealth Group's recent quarterly earnings reported $4.08 per share, missing analysts' expectations, with revenue reaching $111.62 billion, up 12.9% from the previous year.
• The company declared a quarterly dividend of $2.21 per share, which translates to an annual yield of 2.5% with a payout ratio of 38.30%.

Integrity Alliance LLC. increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 376.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 13,395 shares of the healthcare conglomerate's stock after acquiring an additional 10,583 shares during the quarter. Integrity Alliance LLC.'s holdings in UnitedHealth Group were worth $7,016,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Bayforest Capital Ltd boosted its position in shares of UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after purchasing an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd boosted its position in shares of UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after purchasing an additional 50 shares in the last quarter. Copia Wealth Management bought a new position in shares of UnitedHealth Group during the fourth quarter worth $42,000. IAG Wealth Partners LLC bought a new position in shares of UnitedHealth Group during the first quarter worth $42,000. Finally, Investment Management Corp VA ADV bought a new position in shares of UnitedHealth Group during the fourth quarter worth $44,000. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Up 2.1%

Shares of NYSE:UNH traded up $7.11 during midday trading on Thursday, hitting $353.89. The stock had a trading volume of 18,916,413 shares, compared to its average volume of 19,187,298. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The business's 50-day simple moving average is $291.11 and its 200-day simple moving average is $370.48. The company has a market cap of $320.51 billion, a P/E ratio of 15.33, a PEG ratio of 2.27 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same period in the prior year, the business posted $6.80 earnings per share. UnitedHealth Group's quarterly revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be paid a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's dividend payout ratio is 38.30%.

Wall Street Analyst Weigh In

Several research firms recently commented on UNH. KeyCorp cut their price objective on shares of UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating on the stock in a research report on Wednesday, July 30th. Royal Bank Of Canada dropped their price target on UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 30th. HSBC reissued a "reduce" rating and issued a $270.00 price target (down previously from $490.00) on shares of UnitedHealth Group in a research note on Wednesday, May 21st. Wells Fargo & Company cut their price objective on shares of UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating on the stock in a research report on Monday, August 4th. Finally, Hsbc Global Res lowered shares of UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research report on Wednesday, May 21st. Sixteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company's stock. According to MarketBeat, UnitedHealth Group has a consensus rating of "Moderate Buy" and an average target price of $355.77.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.